All participants – Page 10 – Communicable Diseases Research

Antibody Responses After mRNA-Based COVID-19 Vaccination in Residential Older Adults: Implications for Reopening

거주 노인에서 mRNA 기반 COVID-19 백신 접종 후 항체 반응: 재개방에 대한 시사점

Article

Published on 2021-08-012022-09-11
Journal: Journal of the American Medical Directors Associat [Category] SARS, 치료기술,

Low immunogenicity to SARS-CoV-2 vaccination among liver transplant recipients

간 이식 환자 중 SARS-CoV-2 백신 접종에 대한 낮은 면역원성

Article

Published on 2021-08-012022-09-11
Journal: Journal of hepatology [Category] MERS, SARS, 진단, 치료법,

[키워드] age All participant All participants antibody Antibody Response Antibody titer approved average BNT162b2 center Clinical data Control controls COVID-19 COVID-19 infection dose Efficacy elicited enrolled Factor female filtration rate glomerular filtration rate healthy healthy controls healthy volunteer healthy volunteers High dose IgG IgG antibodies Immunity immunogenicity Immunological response immunosuppressive medications include less levels of antibody liver liver transplant Liver transplantation medical records mRNA vaccine mRNA-based vaccine mycophenolate mycophenolate mofetil N-protein nucleocapsid Older age Patient Pfizer Pfizer-BioNTech Pfizer-BioNTech BNT162b2 positive positive serology Prevent receiving recipient recipients regimen renal function reported risk S-protein SARS-CoV-2 SARS-CoV-2 IgG SARS-CoV-2 IgG antibodies SARS-CoV-2 IgG antibody SARS-CoV-2 vaccination SARS-CoV-2 vaccine Serious Adverse Event Serious Adverse Events serological serology Side effect significantly lower Special Population spike-protein steroid Steroids tested the patient Treatment trials vaccination Vaccine vaccine immunogenicity virus was collected
[DOI] 10.1016/j.jhep.2021.04.020 PMC 바로가기 [Article Type] Article

Antibody titres decline 3-month post-vaccination with BNT162b2

항체 역가는 BNT162b2 백신 접종 3개월 후 감소

Multicenter Study

Published on 2021-07-222022-09-10
Journal: Emerging Microbes & Infections [Category] SARS, 진단, 치료법,

[키워드] 95% CI All participants antibody Antibody Response baseline Blood BNT162b2 BNT162b2 mRNA BNT162b2 mRNA COVID-19 vaccine collected Concentration COVID-19 COVID-19 vaccine different time points dose first dose hcp Healthcare professional healthcare professionals humoral Humoral response individual Kinetics kinetics of antibody maximum concentration mRNA vaccine multicentre nucleocapsid Participants Receptor binding domain remained reported robust S1 subunit Sample SARS-CoV-2 SARS-CoV-2 nucleocapsid seronegative seronegative participants seropositive seropositive participants Spike protein subject subjects the antibody response the S1 subunit the SARS-CoV-2 the spike protein titre Vaccination strategy vaccine dose were measured
[DOI] 10.1080/22221751.2021.1953403 PMC 바로가기 [Article Type] Multicenter Study

Longitudinal Serology of SARS-CoV-2-Infected Individuals in India: A Prospective Cohort Study

인도에서 SARS-COV-2- 감염된 개인의 종단 혈청학 : 전향 적 코호트 연구

Articles

Published on 2021-07-182022-09-10
Journal: The American Journal of Tropical Medicine and Hygi [Category] SARS, 진단, 치료법,

[키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 All participant All participants Antigen Asia Asymptomatic Capital Capital Region Characteristics clinical cohorts comparable convalescence coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 epidemiological highlight humoral immune response IgG IgG antibodies IgG antibody immune responses Immunoglobulin Immunoglobulin G immunological characteristics India individual Infection longitudinal Mild mild to moderate moderate multivariable Multivariable regression analysis nasopharyngeal viral nucleocapsid participant positive individuals Postinfection predictor proportion Prospective prospective cohort RBD RBD antigen Receptor binding domain Region regression analysis respiratory response RNA RT-PCR RT-PCR SARS-CoV-2 SARS-CoV-2-positive individual Seroconversion seroconversion rate seroconversion rates serological response serology Seropositivity Serosurveys severe acute respiratory syndrome Coronavirus severe disease severity South subset symptomatic the RBD threshold value Viral were assessed
[DOI] 10.4269/ajtmh.21-0164 PMC 바로가기 [Article Type] Articles

SARS-CoV-2 PCR positivity rate and seroprevalence of related antibodies among a sample of patients in Cairo: Pre-wave 2 results of a screening program in a university hospital

카이로 환자 검체 중 SARS-CoV-2 PCR 양성률 및 관련 항체 혈청 유병률: 대학 병원에서 실시한 검진 프로그램의 Pre-wave 2 결과

Research Article

Published on 2021-07-152022-09-12
Journal: PLoS ONE [Category] MERS, 진단,

Flash glucose monitoring with the FreeStyle Libre 2 compared with self-monitoring of blood glucose in suboptimally controlled type 1 diabetes: the FLASH-UK randomised controlled trial protocol

프리 스타일 Libre 2를 이용한 플래시 포도당 모니터링은 아형 제 1 형 당뇨병에서 혈당의 자체 모니터링과 비교하여 : Flash-UK 무작위 대조 시험 프로토콜

Diabetes and Endocrinology

Published on 2021-07-142022-09-10
Journal: BMJ Open [Category] Fulltext, SARS, 임상,

[키워드] acceptability adjusted adverse event adverse events age All participants analysed Analysis approved baseline baseline value blinded blood glucose clinical trials collected conducted Control covariance COVID-19 pandemic diabete diabetes diabetes & endocrinology doses Efficacy analyses efficacy analysis eight Eligible participants Ethics ethics committee Factor Flash general diabetes Glucose glycaemic control Haemoglobin health economics Health Service include Informed consent insulin intention-to-treat principle Intervention Measures Metrics multicentre National Health Service Open-label Optimising outcome participant Participants performed Perspective potential benefit potential benefits primary care Primary outcome Prognostic factors protocol Psychosocial randomised randomised controlled trial Randomised controlled trials recruit registration number Research Ethics resource secondary Secondary outcomes self-monitoring Standard of care T1D Type 1 diabetes West
[DOI] 10.1136/bmjopen-2021-050713 PMC 바로가기 [Article Type] Diabetes and Endocrinology

Neutralizing Antibodies in COVID-19 Patients and Vaccine Recipients after Two Doses of BNT162b2

BNT162B2의 2 회 용량 후 COVID-19 환자 및 백신 수용자의 중화 항체

Article

Published on 2021-07-142022-09-01
Journal: Viruses [Category] SARS, 진단,

[키워드] All participants analyzed anti-SARS-CoV-2 antibodies anti-SARS-CoV-2 antibody BNT162b2 Complete Covid patients COVID-19 COVID-19 patient COVID-19 patients Diagnosis dose dose regimen first dose generate Humoral response individual infected individual infected individuals long-term kinetics mild patient NAb nAb response NAb titer NAbs neutralization test Neutralizing antibodies neutralizing antibody neutralizing capacity of BNT162b2 P -value participant Participants Patient positive protective immunity pseudovirus recipient recipients remained SARS-CoV-2 second dose serology assays significantly higher surrogate virus neutralization test sVNT vaccinated individuals Vaccine virus neutralization test VNT
[DOI] 10.3390/v13071364 PMC 바로가기 [Article Type] Article

A longitudinal SARS-CoV-2 biorepository for COVID-19 survivors with and without post-acute sequelae

급성 후유증이 있거나없는 코비드 -19 생존자를위한 종 방향 SARS-COV-2 Biorepository

Research Article

Published on 2021-07-132022-09-01
Journal: BMC Infectious Diseases [Category] SARS, 진단,

[키워드] acute COVID-19 acute infection All participants Biobank biobanking Biorepository clinical trial clinically cognitive collected Community coronavirus COVID-19 death demographic data dependent on Diagnosis disease dysfunction enrolled exercise intolerance fatigue Follow-up globe hospital Hospitalization Hospitalized identify Infection initial knowledge Long-hauler longitudinal Loss of Smell loss of taste nasopharyngeal participant PASC pathophysiology Patient PCR phenotype physical positive post infection Post-acute sequelae of COVID-19 (PASC) provide questionnaire recruited reduce Registered reported required Research researcher response responses Result risk Saliva SARS-CoV-2 SARS-COV-2 infection significantly more specimens Spectrum Stool Surveillance survivor Symptom Symptoms symptoms of COVID-19 targeted intervention targeted interventions Taste Treatment vaccination valuable resource Viral viral pathology
[DOI] 10.1186/s12879-021-06359-2 PMC 바로가기 [Article Type] Research Article

Effect of curcumin-pipeine supplementation on clinical status, mortality rate, oxidative stress, and inflammatory markers in critically ill ICU patients with COVID-19: a structured summary of a study protocol for a randomized controlled trial

COVID-19가 있는 중환자 중환자실 환자의 임상 상태, 사망률, 산화 스트레스 및 염증 지표에 대한 커큐민-피페인 보충제의 효과: 무작위 대조 시험을 위한 연구 프로토콜의 구조화된 요약

Letter

Published on 2021-07-062022-09-10
Journal: Trials [Category] SARS, 임상,

[키워드] 1:1 addition Administered All participants allocation sequence ALT anticipated Anticoagulant assigned AST baseline Blinding Blood oxygen saturation C-reactive protein Capsule clinical clinical status Clinical symptoms clinical trial clinical trials CLOCK collected color conducted congenital disorders control group coronavirus COVID-19 creatinine Critically ill CRP Curcumin definitive diagnosis Diseases disorders dissemination double-blind drug Effect Efficacy element eligible patient enteral feeding erythrocyte sedimentation erythrocyte sedimentation rate ESR exclusion criteria Factors female Fever File Hepatic insufficiency hospital ICU ICU patient ICU Patients immune include inclusion criteria independent Inflammatory marker intensive care intensive care unit Intervention intervention group investigators Iran kidney function marker kidney function markers labeling LDH liver male maltodextrin marker matching placebo Medical Sciences Mortality mortality rate normalization number Nurses objective odor outcome oxidative stress oxygen Pancreatitis parameter parenteral nutrition participant Participants Patient PCR test performed physician Physicians piperine Placebo placebo group placebo-controlled Primary outcome protocol provided random randomised randomised controlled trial Randomized Randomized controlled trial Randomly receive recruited Registered registration date registration number registry renal respiratory rate Sample size sealed secondary outcome Secondary outcomes sedimentation rate sensitivity sequence Seven Sex shape status Stratification stratified block randomization study participant Study participants Study protocol supplementary material Support Tablet Taste temperature the placebo group title Trial Trial registration turmeric underlying disease underlying diseases university ventilator Version Warfarin website weight
[DOI] 10.1186/s13063-021-05372-9 PMC 바로가기 [Article Type] Letter

Improvements in clinical signs of Parkinson’s disease using photobiomodulation: a prospective proof-of-concept study

Photobiomodulation을 사용한 파킨슨 병의 임상 징후 개선 : 전향 적 개념 증명 연구

Randomized Controlled Trial

Published on 2021-07-022022-09-10
Journal: BMC Neurology [Category] 비임상,

[키워드] All participants animal model animal models balance best breath clinical Clinical sign Clinical signs clinically Cognition Combination COVID-19 disease dopaminergic neurons dynamic balance Effect effective effective therapy Effectiveness expected help home improvement Improvements incidence individual intranasal measure mitigate Mobility Motor symptoms neurodegenerative neurons New objective Parkinson’s disease Parkinson’s disease participant Participants Photobiomodulation populations PROTECT randomized placebo-controlled trial Randomly RANK RCT recruited reduce Registered registration number registry Result Safe shown Side effect significance level significantly Signs and symptoms supplementary material sustained Symptom threshold Treatment Treatment effectiveness treatment period was used were assessed Wilcoxon Signed Ranks test
[DOI] 10.1186/s12883-021-02248-y PMC 바로가기 [Article Type] Randomized Controlled Trial